Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Status
- TERMINATED
- Phase
- PHASE2
Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.
- Status
- COMPLETED
- Phase
- PHASE3
A Study of AZD8233 in Participants With Dyslipidemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis
- Status
- COMPLETED
- Phase
- PHASE2
AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427
- Status
- COMPLETED
- Phase
- PHASE1
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults
- Status
- COMPLETED
- Phase
- PHASE3
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.
- Status
- COMPLETED
- Phase
- PHASE3
Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.
- Status
- TERMINATED
- Phase
- PHASE3
Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)
- Status
- TERMINATED
- Phase
- PHASE2